Exposure to lead may be linked to cognitive problems decades later, according to three studies presented at the Alzheimer’s ...

Patients who used combinations of cardiovascular therapies experienced slower cognitive decline and fewer neuropathologies ...

Julia A. Haller, MD, ophthalmologist-in-chief at Wills Eye Hospital, has been named CEO, succeeding Joseph P. Bilson, ...

Lyme disease is a complex condition with a long history of misdiagnosis, and Lyme arthritis, a late manifestation of the ...

There was a lot of excitement when Tepezza became the first drug approved for the treatment of thyroid eye disease in January ...

Tirzepatide may confer larger increases in testosterone levels among men with metabolic hypogonadism than testosterone ...

Nicotine ingestions among young children declined 2015, but nicotine pouch ingestions more than 700% 2020, according to a ...

Declining physical activity in the years leading up to a heart-related event was frequent, with even steeper declines ...

A multi-ancestry polygenic risk score could help health care professionals predict a person’s risk for developing obesity ...

Commonly used sulfonylureas were associated with an up to 13% increase in risk for major adverse CV events vs.

A high dose of centanafadine was shown to be safe and effective at lowering ADHD symptoms for adolescents, according to ...

Nephrology has added a number of new training positions to the field in recent years, but interest has not kept pace. A study ...